Skip to content

Malcolm Little

Partner

Malcolm joined Arlington in 2014 and focuses on the Firm’s Healthcare investments. Malcolm was previously a Vice President at Avista Capital Partners where he focused primarily on investments in the healthcare industry. Prior to Avista, he was an Associate at Oak Hill Capital Partners where he was responsible for investments in the firm’s Business and Financial Services industry group. Malcolm also worked at Bear, Stearns & Co. in its Leveraged Finance group.

Malcolm is currently a director of Afton Scientific, AVS Bio, Everest Clinical Research, and Grand River Aseptic Manufacturing.

Education

University of Virginia, B.S., with distinction, Commerce

Harvard Business School, MBA

Current investments

Select prior investments

  • Molecular ProductsAcquired by Filtration Group
  • MicroPactAcquired by Tyler Technologies (NYSE: TYL)
  • Ontario SystemsAcquired by New Mountain Capital
  • Avalign TechnologiesAcquired by Linden Capital Partners